NCT04466098 2025-01-29
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
Clinical Trials
5 trialsNCT04358406 2023-11-28
Rhu-pGSN for Severe Covid-19 Pneumonia
BioAegis Therapeutics Inc.
Phase 2 Completed
NCT04733833 2023-02-01
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
Vascular Biogenics Ltd. operating as VBL Therapeutics
Phase 2 Completed
NCT04333914 2022-09-30
IMMUNONCOVID
Centre Leon Berard
Phase 2 Completed
NCT04453384 2022-03-25
POLYCOR
Nantes University Hospital
Phase 2 Completed